ComplianceFeaturesLegal FTC and FDA Issue Warnings to CBD Marketers May 1, 2019 By Ginny Pasqualone In a rare joint sanctions effort, regulators crack down on product claims, just as cannabidiol products take off. Please log in (or register) to continue viewing this content. Username or E-mail Password Remember Me Forgot Password cannabidoilcbdFarm BillFDAFTCGinny PasqualoneKelly Dryeregulation 0 comment 0 Facebook Twitter Google + Pinterest previous post Do Non-Compete and Non-Solicitation Clauses Hold Up in Court? next post Getting Real with Modere’s CEO Asma Ishaq Related Articles Regulatory Scrutiny Increases December 1, 2019 Massachusetts Latest State to Infringe on IC Status January 1, 2020 Direct Selling Critics Meet for 2nd Virtual Anti-MLM... July 1, 2022 Overcoming Supply Chain Troubles in 2022 March 1, 2022 Industry Grapples with Advance of Crypto Offerings September 6, 2018 FTC Handed Major Courtroom Setback in Anti-Pyramid Case August 1, 2022 Herbalife Buys Back $600 Million in Latest Major... February 1, 2021 LOOK FOR OUR JULY ISSUE IN YOUR MAILBOX.... July 1, 2021 How Pending Legislation Could Affect Your Company’s Compliance... September 1, 2021 LuLaRoe Settles DSA-Supported Lawsuit March 1, 2021
